Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...

Of the total trade in FY24, Indian exports to the US stood at $77.5 billion, while US exports to India stood at $40.7 billion ...

Figure 1: Overall India pharma market growth (left ... the increase in promotional tie-ups between foreign and domestic companies to increase market penetration, how generic manufacturers can ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

His areas of experience include handling complex quality control operations, regulatory compliance, and leadership of large ...

With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...

Currently, US charges nearly zero duties on pharmaceutical imports. India on the other hand imposes around 10 percent tax on ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

The financial services company suggests that India will need to strive harder to gain opportunities from a global tariff war.

The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.

Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...